# Gasdermin D-Mediated Caspase Inhibition: Preventing Pyroptosis New treatment methods offer hope for inflammatory diseases. - **Source:** [Nature](https://brifing.si/source/4d850c3b-dd79-4024-bc91-db2571889199) - **Published:** 2026-08-03 - **Original article:** - **On Brifing:** https://brifing.si/s/c8325e42-e8e8-4a43-8639-da8af475fada ## What is Pyroptosis? Pyroptosis is a form of cell death triggered by Gasdermin D (GSDMD) pores. In this process, caspase-1, -4, -5, and -11 enzymes are activated, leading to the release of interleukin (IL)-1β and IL-18. This mechanism plays a crucial role in the pathogenesis of inflammatory diseases. ## Clinical Failures Cell-permeable caspase inhibitors failed in clinical trials. These inhibitors could not enter healthy cells, limiting their therapeutic effects. This highlighted the need for a new approach. ## New Inhibitors Researchers at Genentech developed covalent caspase inhibitors. These inhibitors selectively block pyroptosis and IL-1β secretion. Despite being excluded from healthy cells, they were effective thanks to GSDMD pores. ## Mechanism GSDMD pores facilitated the uptake of inhibitors into cells. This process involved a temporary increase in membrane permeability, allowing inhibitors to enter. This mechanism was consistent with membrane repair mechanisms. ## Distinct from Apoptosis The new inhibitors did not prevent caspase-driven apoptotic cell death. This finding underscores pyroptosis as a unique mechanism, offering significant potential for targeted therapies. ## Experimental Results In mouse models, inhibition of caspase-1 and -11 suppressed IL-1β and IL-18 production. These results demonstrated therapeutic potential in inflammatory conditions like endotoxic shock. ## Therapeutic Potential Targeted caspase inhibition via GSDMD pores could offer new treatment strategies for inflammatory diseases. This approach has the potential to overcome clinical failures. ## Future Perspectives These findings could usher in a new era in the treatment of inflammatory diseases. Utilizing GSDMD pores as therapeutic targets may lead to more effective and safer treatments. ## Sources covering this story - https://www.nature.com/articles/s41586-026-10957-y — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._